Anti-PD-L1 antibodies
US10954302B2 · kind B2 · utility
7Cited by
13References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2017 |
| Grant date | Mar 23, 2021 |
| Priority date | — |
| Expiry date | Sep 27, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Aspects of the invention include isolated anti-PD-L1 antibodies, as well as compositions containing such antibodies, and methods of using the same in the treatment of diseases or conditions that are mediated by PD-L1 signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.